June 22, 2022

Why Clovis Oncology Stock Is Blasting Off Today

What happened
Shares of Clovis Oncology (NASDAQ: CLVS) headed for the moon on Tuesday after the company reported positive interim phase 1/2 clinical trial results for one of its therapies on June 14, with its shares up by more than 65% as of 11 a.m. ET today before pulling back s

This post was originally published on this site

Sign Up To Get FREE News, Tips and Offers!